Jinhe Biotechnology Co Ltd Cash Flow Conversion Efficiency
Jinhe Biotechnology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jinhe Biotechnology Co Ltd (002688) has a cash flow conversion efficiency ratio of 0.088x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥229.93 Million ≈ $33.65 Million USD) by net assets (CN¥2.60 Billion ≈ $380.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jinhe Biotechnology Co Ltd (2008–2024)
Cash flow conversion efficiency of Jinhe Biotechnology Co Ltd from 2008 to 2024. This chart illustrates how Jinhe Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002688 live share price for real-time trading data and today's change.
Jinhe Biotechnology Co Ltd Cash Flow Conversion Ratio Explained
Jinhe Biotechnology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jinhe Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jinhe Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Jinhe Biotechnology Co Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhangjiagang Freetrade Science and Technology Co Ltd
SHG:600794
|
-0.025x |
|
Shanghai Golden Union Commercial Management Co Ltd
SHG:603682
|
0.144x |
|
More Provident Funds
TA:MPP
|
-0.214x |
|
Tungkong Inc
SHE:002117
|
0.055x |
|
Changhong Meiling Co Ltd
SHE:000521
|
-0.004x |
|
Flushing Financial Corporation
NASDAQ:FFIC
|
0.028x |
|
Tianjin Jiuri New Materials Co Ltd
SHG:688199
|
0.022x |
|
CII Bridges and Roads Investment JSC
VN:LGC
|
0.032x |
Annual Cash Flow Conversion Efficiency for Jinhe Biotechnology Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Jinhe Biotechnology Co Ltd from 2008 to 2024. Review 002688 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.50 Billion ≈ $365.81 Million |
CN¥498.42 Million ≈ $72.94 Million |
0.199x | +152.45% |
| 2023-12-31 | CN¥2.52 Billion ≈ $368.27 Million |
CN¥198.77 Million ≈ $29.09 Million |
0.079x | +53.88% |
| 2022-12-31 | CN¥2.43 Billion ≈ $354.89 Million |
CN¥124.47 Million ≈ $18.21 Million |
0.051x | -9.53% |
| 2021-12-31 | CN¥2.70 Billion ≈ $394.58 Million |
CN¥152.98 Million ≈ $22.39 Million |
0.057x | -61.53% |
| 2020-12-31 | CN¥1.75 Billion ≈ $256.07 Million |
CN¥258.08 Million ≈ $37.77 Million |
0.147x | -5.57% |
| 2019-12-31 | CN¥1.81 Billion ≈ $264.40 Million |
CN¥282.19 Million ≈ $41.29 Million |
0.156x | +137.16% |
| 2018-12-31 | CN¥1.78 Billion ≈ $260.38 Million |
CN¥117.17 Million ≈ $17.15 Million |
0.066x | +295.62% |
| 2017-12-31 | CN¥1.64 Billion ≈ $239.59 Million |
CN¥27.25 Million ≈ $3.99 Million |
0.017x | -90.98% |
| 2016-12-31 | CN¥1.58 Billion ≈ $231.81 Million |
CN¥292.41 Million ≈ $42.79 Million |
0.185x | -9.45% |
| 2015-12-31 | CN¥1.05 Billion ≈ $154.31 Million |
CN¥214.97 Million ≈ $31.46 Million |
0.204x | +435.95% |
| 2014-12-31 | CN¥956.13 Million ≈ $139.91 Million |
CN¥-58.02 Million ≈ $-8.49 Million |
-0.061x | -136.82% |
| 2013-12-31 | CN¥900.07 Million ≈ $131.71 Million |
CN¥148.32 Million ≈ $21.70 Million |
0.165x | +60.24% |
| 2012-12-31 | CN¥863.55 Million ≈ $126.36 Million |
CN¥88.81 Million ≈ $13.00 Million |
0.103x | -67.74% |
| 2011-12-31 | CN¥334.40 Million ≈ $48.93 Million |
CN¥106.59 Million ≈ $15.60 Million |
0.319x | -31.19% |
| 2010-12-31 | CN¥254.83 Million ≈ $37.29 Million |
CN¥118.05 Million ≈ $17.27 Million |
0.463x | +291.50% |
| 2009-12-31 | CN¥196.03 Million ≈ $28.69 Million |
CN¥23.20 Million ≈ $3.39 Million |
0.118x | +80.81% |
| 2008-12-31 | CN¥177.82 Million ≈ $26.02 Million |
CN¥11.64 Million ≈ $1.70 Million |
0.065x | -- |
About Jinhe Biotechnology Co Ltd
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China.